Dear Reader ,
Here is your customized PHYSorg.com Newsletter for September 19, 2010:
Spotlight Stories Headlines
- Two studies find new genetic links to ovarian cancer risk- Nano-Vehicle acts as cluster bomb for tumors
- Better marker for breast cancer may reduce need for second surgeries
- Microsoft, Yahoo! jostle for US search share
- Biochemical link between biological clock and diabetes discovered
- Rutgers researchers discover how HIV resists AZT
- Spiriva as good as Serevent in asthma study
Space & Earth news
Busted well to be 'completely sealed' by Saturday
BP was set Saturday to cap a months-long effort to end the worst maritime oil spill in history with a death choke that will permanently seal its ruptured Gulf of Mexico well.
Technology news
WikiLeaks founder 'free to leave Sweden'
WikiLeaks founder Julian Assange is free to leave Sweden, after prosecutors said there was no arrest warrant against him for an alleged case of rape, one of his lawyers said Saturday.
1,000 computer hackers meet in Budapest
Hacktivity 2010, the largest computer hackers' conference in eastern Europe, kicked off Saturday, with some 1,000 participants expected to attend the two-day event, according to organisers.
Facebook fervor feeds 'The Social Network' fascination
Promises of elitism, geekdom, betrayal and greed are fueling anticipation for the October 1 release of "The Social Network," Hollywood's take on the birth of social networking king Facebook.
Strong German opposition to Google Street View: report
Google is facing even more opposition in Germany than it expected to its Street View navigation service, with hundreds of thousands opting out, Der Spiegel news weekly reports in its Monday issue.
EU acts to extend digital switchover to remote and elderly
Regulators will bid Monday to extend mobile Internet access to Europe's farthest flung outposts by opening up commercial rights to the analogue broadcasting spectrum.
Microsoft, Yahoo! jostle for US search share
Google is the undisputed king of search in the United States, but the question remains, who's number two?
Medicine & Health news
Mechanism behind demethylation pinpointed in APC gene mutants
Researchers at Huntsman Cancer Institute at the University of Utah demonstrate in a study featured in Cell the mechanism by which mutation of the APC gene affects a cellular process known as DNA methylation.
Californians face whooping cough outbreak
Californians are rushing to get themselves inoculated against a whooping cough epidemic which has claimed the lives of several babies.
Targeted therapy decreases progression rate in thyroid cancer
The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology.
Possible alternate therapy for adults with poorly controlled asthma
A drug commonly used for the treatment of chronic obstructive pulmonary disease (COPD) successfully treats adults whose asthma is not well-controlled on low doses of inhaled corticosteroids, reported researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
Researchers discover genetic variants modifying breast cancer risk
Individuals with disrupting mutations in the BRCA1 gene are known to be at substantially increased risk of breast cancer throughout their lives. Now, discoveries from an international research team led by Mayo Clinic researchers show that some of those persons may possess additional genetic variants that modify their risk. These new findings enhancing individualized medicine appear in the current Nature Genetics.
Better marker for breast cancer may reduce need for second surgeries
A new material could help surgeons more accurately locate breast cancers, reduce the need for second surgeries and minimize pre-surgical discomfort for patients. Microscopic gas-filled spheres of silica, a porous glass, can mark the location of early-stage tumors to show their position using ultrasound imaging in the operating room.
Rutgers researchers discover how HIV resists AZT
Rutgers researchers have discovered how HIV-1, the virus that causes AIDS, resists AZT, a drug widely used to treat AIDS.
Spiriva as good as Serevent in asthma study
(AP) -- Researchers say they've found a possible new treatment for adults with hard-to-control asthma. Their discovery, however, came at a price.
Two studies find new genetic links to ovarian cancer risk
An international consortium of scientists has discovered new genetic variants in five regions of the genome that affect the risk of ovarian cancer in the general population, according to two separate studies published today, online in Nature Genetics.
Biology news
Germany's giant beer party deploys stench-eating bacteria
Germany's giant Oktoberfest beer party, now celebrating its 200th birthday, is rising to a new challenge -- stinky drinking halls -- with a new weapon: stench-eating bacteria.
This email is a free service of PhysOrg.com
You received this email because you subscribed to our list.
If you no longer want to receive this email use the link below to unsubscribe.
http://www.physorg.com/profile/nwletter/
You are subscribed as mail@joashmabs.com
No comments:
Post a Comment